Limitations, agreements, and source contact

Cabozantinib for Advanced Urothelial Cancer · Source last updated 2022-10-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

apoloab@nih.gov

organization

National Cancer Institute

phone

301-480-0536

title

Dr. Andrea Apolo

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice